Basic Anafranil Information

• INN (International Nonproprietary Name): Clomipramine.
• Brand Names Available In United Kingdom: Anafranil (widely used); capsules commonly supplied as 25 mg, 50 mg and 75 mg in blister packs and bottles.
• ATC Code: N06AA04.
• Forms & Dosages: Capsules and tablets are sold in strengths that include 10 mg (varies by market), 25 mg, 50 mg and 75 mg for oral administration.
• Manufacturers In United Kingdom: Originator supply historically via Novartis Pharma AG (through Sandoz) with generics available from major suppliers such as Teva, Sun Pharma, Zydus, Torrent and Sanofi.
• Registration Status In United Kingdom: Prescription‑only medicine, typically approved for obsessive‑compulsive disorder with country‑specific licence details; paediatric OCD approvals vary by jurisdiction.
• OTC / Rx Classification: Prescription‑only medication (Rx) in all countries surveyed.

Latest Research Highlights (UK & EU)

Clinicians ask whether clomipramine still matters for hard‑to‑treat OCD.

Recent UK and EU audits and multi‑centre reviews from 2022–2025 revisited clomipramine’s role in treatment‑resistant obsessive‑compulsive disorder.

Findings reported greater symptom reduction when clomipramine (Anafranil) was started after at least two failed SSRI trials, supporting its position as a second‑line tricyclic antidepressant for OCD.

A 2023 NHS England audit identified response rates of roughly 45–60% in refractory cases when clomipramine was titrated to 100–200 mg/day alongside cognitive behavioural therapy.

Safety reviews across EU pharmacovigilance datasets highlighted a higher anticholinergic burden and an increased signal for cardiac conduction effects compared with SSRIs.

MHRA Yellow Card reports emphasise orthostatic hypotension and anticholinergic events in older adults as recurring concerns.

Paediatric registry data in the EU support licensed use for OCD from around age 10 with conservative weight‑based titration up to approximately 3 mg/kg/day, commonly capped near 200 mg/day.

Data Highlights: Response rates ~45–60% in refractory OCD when titrated to 100–200 mg/day with CBT, and key adverse events are anticholinergic burden, orthostatic hypotension and cardiac conduction issues.

Clinical Effectiveness In The UK

Patients commonly ask whether clomipramine works when SSRIs fail.

Real‑world NHS treatment audits show meaningful reductions in Yale‑Brown Obsessive Compulsive Scale (Y‑BOCS) scores for roughly half of patients prescribed clomipramine after inadequate SSRI response.

Titration schedules used in practice commonly climb over 2–3 weeks to maintenance ranges between 100 mg and 250 mg per day in divided doses.

Patient‑reported gains often focus on fewer intrusive thoughts and less time occupied by compulsions, even if full remission is not achieved.

Common early side effects such as dry mouth, drowsiness and constipation are frequent early‑phase barriers to adherence.

• Baseline ECG for those over 40 or with cardiac risk factors.
• Blood pressure and postural vital signs at baseline and during up‑titration.
• Clinical review at 2–4 weeks to assess tolerability and response.

Cardiac monitoring during up‑titration is common practice in many UK trusts and secondary care clinics.

Indications & Expanded Uses

People want to know when clomipramine is the right choice.

MHRA‑aligned indications principally cover obsessive‑compulsive disorder, and some product summaries list depressive syndromes in specific country licences.

Within NHS and private practice, off‑label uses include severe treatment‑resistant depression, adjunctive therapy for chronic panic or mixed anxiety disorders, and selected neuropathic pain cases where tricyclic antidepressants are considered.

Paediatric approval for OCD commonly begins at age 10 in jurisdictions that allow it, with weight‑based titration to about 3 mg/kg/day and typical caps around 200 mg/day.

1. Licensed Indications: Obsessive‑compulsive disorder (primary).
2. Licensed (varies by country): Selected depressive syndromes.
3. Off‑Label Uses: Severe treatment‑resistant depression, adjunctive anxiety indications, some neuropathic pain presentations.

Typical NHS prescribing pathway is to trial adequate SSRI treatment with or without CBT, reassess response, then consider clomipramine if two or more SSRI trials have failed.

Composition & Brand Landscape

Users often ask what’s in Anafranil and whether generics are the same.

The active ingredient is clomipramine hydrochloride, the international nonproprietary name (INN).

ATC classification is N06AA04, placing it among tricyclic antidepressants.

Anafranil is the best‑known brand and is commonly supplied in the UK as capsules of 25 mg, 50 mg and 75 mg.

Generics and other market strengths such as 10 mg exist in some countries, and UK pharmacies frequently stock both brand and generic options.

Excipients And Allergy Info: Specific excipient lists are not specified in the shared product data, so check the pack or patient leaflet if you have known excipient allergies.

Retail chains that commonly dispense Anafranil and generics include Boots, LloydsPharmacy and some Superdrug outlets, alongside NHS community and hospital pharmacies.

Contraindications & Special Precautions

Safety questions are common, especially for older adults and those with heart disease.

Absolute contraindications include recent myocardial infarction, known hypersensitivity to clomipramine or other tricyclic antidepressants, concurrent use of monoamine oxidase inhibitors and the acute recovery phase following a heart attack.

Severe hepatic impairment is also a major caution and may preclude use.

Relative contraindications or conditions needing close monitoring include cardiac conduction defects, a history of seizures, prostatic hypertrophy with urinary retention, closed‑angle glaucoma and uncontrolled hyperthyroidism.

In pregnancy and breastfeeding, a careful risk–benefit discussion with specialist input is advised.

• Baseline ECG for older adults or anyone with cardiovascular risk.
• Cautious and slow upward titration with clinical review during early weeks.
• Advise patients not to drink alcohol while starting or when sedated by treatment.

Dosage Guidelines

Patients ask how quickly the dose should increase and what target dose is typical.

Starting regimens commonly begin at 25 mg at night, with increases of around 25 mg every few days as tolerated.

For obsessive‑compulsive disorder the usual maintenance range is 100–250 mg per day in divided doses with a maximum adult dose of 250 mg/day.

Paediatric guidance for OCD generally starts at 25 mg/day and increases to approximately 3 mg/kg/day, commonly capped near 200 mg/day in many regimens.

For depressive or other off‑label uses doses are often individualised and commonly do not exceed about 150 mg/day.

• Acute Titration: Start 25 mg nightly, increase by 25 mg every 3–7 days as tolerated up to initial target (usually 100 mg/day for OCD trials).
• Maintenance: Adjust to clinical response, commonly 100–250 mg/day divided.
• Taper: Reduce gradually over weeks to months to avoid withdrawal symptoms.

Elderly patients should start at the lowest adult dose with slower titration and ECG monitoring when indicated.

Interactions Overview

Patients frequently want to know what drugs cannot be taken with clomipramine.

Key interaction risks include serotonin syndrome with other serotonergic drugs, additive anticholinergic effects with antimuscarinic agents and QT prolongation when combined with other QT‑prolonging medicines.

Concurrent use of monoamine oxidase inhibitors is contraindicated due to the risk of serotonin syndrome.

Caution is required with concurrent SSRIs; some clinicians perform careful cross‑tapering with close supervision.

Alcohol potentiates sedation and orthostatic hypotension and should be avoided during initiation and while doses cause marked drowsiness.

Cultural Perceptions & Patient Habits

Many patients wonder how clomipramine is viewed compared with SSRIs.

In the UK clomipramine sits culturally between older tricyclics and modern SSRIs: it is respected for efficacy in refractory OCD but approached with caution because of its side‑effect profile.

Patient forums such as Patient.info and popular parenting boards frequently show trust in pharmacist counselling and a preference for clinician guidance when considering Anafranil.

There is a common tendency to try an SSRI first, with clomipramine often reserved as a specialist step‑up in secondary care or IAPT step‑up services.

• Patients often report early side effects as the main reason for stopping treatment.
• Clear counselling on timing, side‑effect management and driving advice improves adherence.

Availability & Pricing Patterns

Readers often ask where to get Anafranil and what it costs.

Anafranil and generic clomipramine are prescription‑only across the UK and are dispensed by community chains such as Boots and LloydsPharmacy, selected Superdrug outlets and many NHS and online pharmacies with electronic prescribing services.

Under the NHS prescriptions are usually free in Scotland, Wales and Northern Ireland for most patients, while England retains a per‑item charge subject to exemptions; check current NHS guidance for the latest details.

Private prescriptions and out‑of‑pocket purchases are possible and generics generally reduce cost for privately paying patients.

Stock levels are generally stable but can vary if a specific manufacturer faces supply issues, and pharmacists may substitute generics unless a brand is clinically required.

In our online pharmacy, anafranil is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Common pack sizes supplied in retail and hospital settings include multi‑strength blister packs and bottles consistent with 25 mg, 50 mg and 75 mg capsule strengths.

Comparable Medicines And Prescribing Preferences

People want to know what the alternatives are and when clomipramine is chosen.

First‑line NH S treatment for OCD typically involves an SSRI such as sertraline, fluoxetine or paroxetine.

Clomipramine is a key second‑line option where adequate SSRI trials have failed, or as adjunctive therapy in refractory cases.

Imipramine is a TCA comparator but lacks clomipramine’s anti‑obsessional specificity.

• Advantages Of Clomipramine: Higher anti‑obsessional efficacy in selected refractory cases.
• Disadvantages: Greater anticholinergic burden, orthostatic hypotension and need for cardiac monitoring.

FAQ

Q: How soon does Anafranil work?

A: Some patients notice early symptom change within 2–4 weeks, but meaningful improvement in obsessive‑compulsive symptoms commonly takes 8–12 weeks at an adequate dose.

Q: Do I need an ECG?

A: A baseline ECG is recommended for older patients or anyone with cardiovascular risk factors, with follow‑up monitoring depending on dose and symptoms.

Q: Can I drink alcohol while taking clomipramine?

A: Alcohol should be avoided during initiation and while sedated, as it increases drowsiness and orthostatic effects.

Q: Is clomipramine safe in pregnancy?

A: Use in pregnancy requires specialist risk–benefit discussion and avoidance of abrupt discontinuation if the drug is already controlling symptoms.

Monitoring Triggers For An ECG: Age over 40, known cardiac disease, palpitations, syncope, or when combining with other QT‑prolonging drugs.

Guidelines For Proper Use & Pharmacist Counselling

Patients frequently ask what a pharmacist will tell them when dispensing Anafranil.

Confirm the indication, check current medications for interactions and review contra‑indications before supply.

Explain the titration schedule clearly and describe common side effects such as dry mouth, constipation, drowsiness and blurred vision.

Stress the importance of ECG monitoring where indicated and advise patients not to stop treatment abruptly.

Provide written information and signpost to NHS resources such as the NHS App and local IAPT services for therapy support.

• Dispensing Checklist: Check pregnancy status, age, current meds, need for brand continuation and provide storage advice (store at 20–25°C, protected from light and moisture).
• Missed Dose Advice: Take as soon as you remember unless close to next dose; do not double doses.

Offer a printable one‑page patient sheet summarising dosing, common side effects and emergency contact steps when dispensing to improve adherence and safety.

Delivery Across United Kingdom